Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Comprehensive Value Strategy Delivering Strong Results and Returns for Shareholders Diana Shipping’s Proposal Substantially Undervalues Genco and Fails to Provide Appropriate Premium to Shareholders...
-
Results from pediatric patients in the SAVE Registry shows no device-related adverse events or immunosuppression and continued strong survival data In vitro analysis of the SeaStar Medical SCD...
-
– Analysis Demonstrated 22% Reduced Risk of Ischemic Stroke for Patients Taking Bempedoic Acid Compared to Placebo – – Analysis of CLEAR Outcomes Reports Bempedoic Acid Reduced MACE in High-Risk...
-
-- Studies highlight reduced total cost of care and select healthcare resource utilization outcomes in total knee arthroplasty (TKA) and spinal fusion -- BRISBANE, Calif., March 30, 2026 (GLOBE...
-
MediPharm Labs, today announced its financial results for the full year and three months ended December 31st, 2025.
-
Jena, Germany, March 30, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today...
-
CALGARY, Alberta, March 30, 2026 (GLOBE NEWSWIRE) -- A new 2026 survey commissioned by H&R Block Canada reveals that Canadians believe that the gig economy hasn’t only evolved the traditional...
-
Aura Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Accelerated Phase 3 CoMpass Enrollment Supports Mid-2026 Enrollment Completion and 2H 2027 Topline Data Guidance Phase 1b/2 NMIBC Trial on Track: Initial 3-Month Clinical Data Expected Mid-2026 ...
-
HIGHLIGHTS: 174,000 meters of exploration and grade control drilling conducted in 2025, with 36% directed towards the Koné and Gbongogo Main deposits, in addition to delineating new higher-grade...
-
EBITDA of €66.7 million (+9.1%) Current operating income of €48.2 million (+6.8%) Net profit increased by 8.8% to €41.1 million